Concepedia

W. Kim

WK

Statistics

Publications

3

Citations

57

H-Index

3

Active since

2010

Affiliations

Samsung Medical Center(Current)

Sungkyunkwan University

W. Kim is an author at Samsung Medical Center specializing in medicine, oncology, and cancer pharmacology.

Publications per year

2010–2021

3

Publications

3

UPDATED SAFETY AND EFFICACY DATA IN THE PHASE 1 TRIAL OF PATIENTS WITH MANTLE CELL LYMPHOMA (MCL) TREATED WITH BRUTON TYROSINE KINASE (BTK) INHIBITOR ZANUBRUTINIB (BGB‐3111)

Constantine S. Tam, M. Wang, David Simpson et al. · Hematological Oncology · 2019 · 28 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II study of SMILE chemotherapy for newly-diagnosed stage IV, relapsed or refractory extranodal NK/T-cell lymphoma, nasal type: NKTSG study.

M. Yamaguchi, Yok‐Lam Kwong, Yusuke Maeda et al. · Journal of Clinical Oncology · 2010 · 16 citations

Medicine, Oncology, Cancer Immunology +8

SO-31 ASPEN-01: A phase 1 study of ALX148, a CD47 blocker, in combination with trastuzumab, ramucirumab and paclitaxel in patients with second-line HER2-positive advanced gastric or gastroesophageal junction cancer

Hyun Cheol Chung, Kyungwon Lee, W. Kim et al. · Annals of Oncology · 2021 · 13 citations · Full text

Medicine, Oncology, Pharmacology +15

1–3 of 3